全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
PLOS ONE  2014 

Survival on Home Dialysis in New Zealand

DOI: 10.1371/journal.pone.0096847

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background New Zealand (NZ) has a high prevalence of both peritoneal dialysis (PD) and home haemodialysis (HD) relative to other countries, and probably less selection bias. We aimed to determine if home dialysis associates with better survival than facility HD by simultaneous comparisons of the three modalities. Methods We analysed survival by time-varying dialysis modality in New Zealanders over a 15-year period to 31-Dec-2011, adjusting for patient co-morbidity by Cox proportional hazards multivariate regression. Results We modelled 6,419 patients with 3,254 deaths over 20,042 patient-years of follow-up. Patients treated with PD and facility HD are similar; those on home HD are younger and healthier. Compared to facility HD, home dialysis (as a unified category) associates with an overall 13% lower mortality risk. Home HD associates with a 52% lower mortality risk. PD associates with a 20% lower mortality risk in the early period (<3 years) that is offset by a 33% greater mortality risk in the late period (>3 years), with no overall net effect. There was effect modification and less observable benefit associated with PD in those with diabetes mellitus, co-morbidity, and in NZ Maori and Pacific People. There was no effect modification by age or by era. Conclusion Our study supports the culture of home dialysis in NZ, and suggests that the extent and duration of survival benefit associated with early PD may be greater than appreciated. We are planning further analyses to exclude residual confounding from unmeasured co-morbidity and other sociodemographic factors using database linkage to NZ government datasets. Finally, our results suggest further research into the practice of PD in NZ Maori and Pacific People, as well as definitive study to determine the best timing for switching from PD in the late phase.

References

[1]  Lynn KL, Buttimore AL (2005) Future of home haemodialysis in Australia and New Zealand. Nephrology (Carlton) 10: 231–233.
[2]  McGregor D, Buttimore A, Robson R, Little P, Morton J, et al. (2000) Thirty years of universal home dialysis in Christchurch. N Z Med J 113: 27–29.
[3]  Blagg CR (2005) Home haemodialysis: ‘home, home, sweet, sweet home!’. Nephrology (Carlton) 10: 206–214.
[4]  Marshall MR, Hawley CM, Kerr PG, Polkinghorne KR, Marshall RJ, et al. (2011) Home hemodialysis and mortality risk in Australian and New Zealand populations. Am J Kidney Dis 58: 782–793.
[5]  Wyld M, Morton RL, Hayen A, Howard K, Webster AC (2012) A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. PLoS Med 9: e1001307.
[6]  Dale PL, Hutton J, Elgazzar H (2008) Utility of health states in chronic kidney disease: a structured review of the literature. Curr Med Res Opin 24: 193–206.
[7]  Mowatt G, Vale L, MacLeod A (2004) Systematic review of the effectiveness of home versus hospital or satellite unit hemodialysis for people with end-stage renal failure. Int J Technol Assess Health Care 20: 258–268.
[8]  Mowatt G, Vale L, Perez J, Wyness L, Fraser C, et al. (2003) Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure. Health Technol Assess 7: 1–174.
[9]  National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (2012) U.S. Renal Data System, USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States.
[10]  Chan CT, Lok CE (2009) Why not home dialysis? Adv Chronic Kidney Dis 16: 158–159.
[11]  Golper TA, Guest S, Glickman JD, Turk J, Pulliam JP (2011) Home Dialysis in the new USA Bundled Payment Plan: Implications and Impact. Peritoneal Dialysis International 31: 12–16.
[12]  Thodis ED, Oreopoulos DG (2011) Home dialysis first: a new paradigm for new ESRD patients. J Nephrol 24: 398–404.
[13]  Vonesh E, Schaubel D, Hao W, Collins A (2000) Statistical methods for comparing mortality among ESRD pateints: Examples of regional/international variations. Kidney Int 57: S19–S27.
[14]  The Australia and New Zealand Dialysis and Transplant Registry. Adelaide, Australia: ANZDATA Registry.
[15]  Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461–470.
[16]  Mailloux LU, Bellucci AG, Mossey RT, Napolitano B, Moore T, et al. (1988) Predictors of survival in patients undergoing dialysis. American Journal of Medicine 84: 855–862.
[17]  Mailloux LU, Bellucci AG, Napolitano B, Mossey T, Wilkes BM, et al. (1994) Survival estimates for 683 patients starting dialysis from 1970 through 1989: Identification of risk factors for survival. Clinical Nephrology 42: 127–135.
[18]  Mailloux LU, Kapikian N, Napolitano B, Mossey RT, Bellucci AG, et al. (1996) Home hemodialysis: patient outcomes during a 24-year period of time from 1970 through 1993. Adv Ren Replace Ther 3: 112–119.
[19]  Prowant B, Nolph KD, Dutton S, et al. (1983) Actuarial analysis of patient survival and dropout with various end-stage renal disease therapies. American Journal of Kidney Diseases 3: 27–31.
[20]  Saner E, Nitsch D, Descoeudres C, Frey FJ, Uehlinger DE (2005) Outcome of home haemodialysis patients: a case-cohort study. Nephrol Dial Transplant 20: 604–610.
[21]  Weller JM, Port FK, Swartz RD, Ferguson CW, Williams GW, et al. (1982) Analysis of survival of end-stage renal disease patients. Kidney Int 21: 78–83.
[22]  Williams GW, Weller JM, Ferguson CW, Forsythe SB, Wu SC (1983) Survival of endstage renal disease patients: age-adjusted differences in treatment outcomes. Kidney Int 24: 691–693.
[23]  Woods JD, Port FK, Stannard D, Blagg CR, Held PJ (1996) Comparison of mortality with home hemodialysis and center hemodialysis: a national study. Kidney Int 49: 1464–1470.
[24]  Rubin J, Barnes T, Bower J (1985) Morbidity and mortality in CAPD and home hemodialysis: One Center’s five-year experience. ASAIO Journal 8: 22–27.
[25]  Rubin J, Barnes T, Burns P, et al. (1983) Comparison of home hemodialysis to continuous ambulatory peritoneal dialysis. Kidney International 23: 51–56.
[26]  Rubin J, Hsu H, Bower J (1989) Survival on dialysis therapy: One center’s experience. American Journal of the Medical Sciences 297: 80–90.
[27]  Grant AC, Rodger RSC, Howie CA, Junor BJR, Briggs JD, et al. (1992) Dialysis at home in the west of Scotland: A comparison of hemodialysis and continuous ambulatory peritoneal dialysis in age- and sex-matched controls. Peritoneal Dialysis International 12: 365–368.
[28]  Nitsch D, Steenkamp R, Tomson CR, Roderick P, Ansell D, et al. (2011) Outcomes in patients on home haemodialysis in England and Wales, 1997–2005: a comparative cohort analysis. Nephrol Dial Transplant 26: 1670–1677.
[29]  Heaf JG, Lokkegaard H, Madsen M (2002) Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant 17: 112–117.
[30]  Termorshuizen F, Korevaar JC, Dekker FW, Van Manen JG, Boeschoten EW, et al. (2003) Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol 14: 2851–2860.
[31]  Jaar BG, Coresh J, Plantinga LC, Fink NE, Klag MJ, et al. (2005) Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med 143: 174–183.
[32]  McDonald SP, Marshall MR, Johnson DW, Polkinghorne KR (2009) Relationship between dialysis modality and mortality. J Am Soc Nephrol 20: 155–163.
[33]  Schaubel DE, Morrison HI, Fenton SS (1998) Comparing mortality rates on CAPD/CCPD and hemodialysis. The Canadian experience: fact or fiction? Perit Dial Int 18: 478–484.
[34]  Vonesh EF, Snyder JJ, Foley RN, Collins AJ (2004) The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 66: 2389–2401.
[35]  Vonesh EF, Snyder JJ, Foley RN, Collins AJ (2006) Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? Kidney Int Suppl: S3–11.
[36]  Collins AJ, Hao W, Xia H, Ebben JP, Everson SE, et al. (1999) Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 34: 1065–1074.
[37]  Ganesh SK, Hulbert-Shearon T, Port FK, Eagle K, Stack AG (2003) Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 14: 415–424.
[38]  Stack AG, Molony DA, Rahman NS, Dosekun A, Murthy B (2003) Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. Kidney Int 64: 1071–1079.
[39]  Stack AG, Murthy BV, Molony DA (2004) Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States. Kidney Int 65: 2398–2408.
[40]  Winkelmayer WC, Glynn RJ, Mittleman MA, Levin R, Pliskin JS, et al. (2002) Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: a propensity score approach. J Am Soc Nephrol 13: 2353–2362.
[41]  Abbott KC, Glanton CW, Trespalacios FC, Oliver DK, Ortiz MI, et al. (2004) Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study. Kidney Int 65: 597–605.
[42]  Snyder JJ, Foley RN, Gilbertson DT, Vonesh EF, Collins AJ (2003) Body size and outcomes on peritoneal dialysis in the United States. Kidney Int 64: 1838–1844.
[43]  Inrig JK, Sun JL, Yang Q, Briley LP, Szczech LA (2006) Mortality by dialysis modality among patients who have end-stage renal disease and are awaiting renal transplantation. Clin J Am Soc Nephrol 1: 774–779.
[44]  Churchill DN, Thorpe KE, Vonesh EF, Keshaviah PR (1997) Lower probability of patient survival with continuous peritoneal dialysis in the United States compared with Canada. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 8: 965–971.
[45]  Vonesh EF, Moran J (1999) Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 10: 354–365.
[46]  Sanabria M, Munoz J, Trillos C, Hernandez G, Latorre C, et al.. (2008) Dialysis outcomes in Colombia (DOC) study: a comparison of patient survival on peritoneal dialysis vs hemodialysis in Colombia. Kidney Int Suppl: S165–172.
[47]  Xu R, Han Q-F, Zhu T-Y, Ren Y-P, Chen J-H, et al. (2012) Impact of Individual and Environmental Socioeconomic Status on Peritoneal Dialysis Outcomes: A Retrospective Multicenter Cohort Study. PLoS ONE 7: e50766.
[48]  Rodriguez RA (2012) Dialysis and mortality: does it matter where you live? Clin J Am Soc Nephrol 7: 1055–1057.
[49]  Tonelli M, Hemmelgarn B, Culleton B, Klarenbach S, Gill JS, et al. (2007) Mortality of Canadians treated by peritoneal dialysis in remote locations. Kidney Int 72: 1023–1028.
[50]  Christensen AJ, Smith TW, Turner CW, Holman JM Jr, Gregory MC (1990) Type of hemodialysis and preference for behavioral involvement: interactive effects on adherence in end-stage renal disease. Health Psychol 9: 225–236.
[51]  Kraus M, Burkart J, Hegeman R, Solomon R, Coplon N, et al. (2007) A comparison of center-based vs. home-based daily hemodialysis for patients with end-stage renal disease. Hemodial Int 11: 468–477.
[52]  Polaschek N (2007) Client attitudes towards home dialysis therapy. Edtna-Erca Journal 33: 20–24.
[53]  Christensen AJ, Smith TW, Turner CW, Holman JM Jr, Gregory MC, et al. (1992) Family support, physical impairment, and adherence in hemodialysis: an investigation of main and buffering effects. J Behav Med 15: 313–325.
[54]  Snyder WL (1977) Factors affecting adherence to diet and medication orders by hemodialysis patients. Abstracts of Hospital Management Studies 14: 18102 PA: 18167p.
[55]  McGregor DO, Buttimore AL, Lynn KL, Nicholls MG, Jardine DL (2001) A comparative study of blood pressure control with short in-center versus long home hemodialysis. Blood Purification 19: 293–300.
[56]  Lameire N, Van Biesen W, Vanholder R (2000) The role of peritoneal dialysis as first modality in an integrative approach to patients with end-stage renal disease. Perit Dial Int 20 Suppl 2S134–141.
[57]  Van Biesen W, Vanholder RC, Veys N, Dhondt A, Lameire NH (2000) An evaluation of an integrative care approach for end-stage renal disease patients. J Am Soc Nephrol 11: 116–125.
[58]  Boissinot L, Landru I, Cardineau E, Zagdoun E, Ryckelycnk JP, et al. (2013) Is transition between peritoneal dialysis and hemodialysis really a gradual process? Perit Dial Int 33: 391–397.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133